HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study.

AbstractBACKGROUND:
Despite circumstantial evidence for aerosol and fomite spread of SARS-CoV-2, empirical data linking either pathway with transmission are scarce. Here we aimed to assess whether the presence of SARS-CoV-2 on frequently-touched surfaces and residents' hands was a predictor of SARS-CoV-2 household transmission.
METHODS:
In this longitudinal cohort study, during the pre-alpha (September to December, 2020) and alpha (B.1.1.7; December, 2020, to April, 2021) SARS-CoV-2 variant waves, we prospectively recruited contacts from households exposed to newly diagnosed COVID-19 primary cases, in London, UK. To maximally capture transmission events, contacts were recruited regardless of symptom status and serially tested for SARS-CoV-2 infection by RT-PCR on upper respiratory tract (URT) samples and, in a subcohort, by serial serology. Contacts' hands, primary cases' hands, and frequently-touched surface-samples from communal areas were tested for SARS-CoV-2 RNA. SARS-CoV-2 URT isolates from 25 primary case-contact pairs underwent whole-genome sequencing (WGS).
FINDINGS:
From Aug 1, 2020, until March 31, 2021, 620 contacts of PCR-confirmed SARS-CoV-2-infected primary cases were recruited. 414 household contacts (from 279 households) with available serial URT PCR results were analysed in the full household contacts' cohort, and of those, 134 contacts with available longitudinal serology data and not vaccinated pre-enrolment were analysed in the serology subcohort. Household infection rate was 28·4% (95% CI 20·8-37·5) for pre-alpha-exposed contacts and 51·8% (42·5-61·0) for alpha-exposed contacts (p=0·0047). Primary cases' URT RNA viral load did not correlate with transmission, but was associated with detection of SARS-CoV-2 RNA on their hands (p=0·031). SARS-CoV-2 detected on primary cases' hands, in turn, predicted contacts' risk of infection (adjusted relative risk [aRR]=1·70 [95% CI 1·24-2·31]), as did SARS-CoV-2 RNA presence on household surfaces (aRR=1·66 [1·09-2·55]) and contacts' hands (aRR=2·06 [1·57-2·69]). In six contacts with an initial negative URT PCR result, hand-swab (n=3) and household surface-swab (n=3) PCR positivity preceded URT PCR positivity. WGS corroborated household transmission.
INTERPRETATION:
Presence of SARS-CoV-2 RNA on primary cases' and contacts' hands and on frequently-touched household surfaces associates with transmission, identifying these as potential vectors for spread in households.
FUNDING:
National Institute for Health Research Health Protection Research Unit in Respiratory Infections, Medical Research Council.
AuthorsNieves Derqui, Aleksandra Koycheva, Jie Zhou, Timesh D Pillay, Michael A Crone, Seran Hakki, Joe Fenn, Rhia Kundu, Robert Varro, Emily Conibear, Kieran J Madon, Jack L Barnett, Hamish Houston, Anika Singanayagam, Janakan S Narean, Mica R Tolosa-Wright, Lucy Mosscrop, Carolina Rosadas, Patricia Watber, Charlotte Anderson, Eleanor Parker, Paul S Freemont, Neil M Ferguson, Maria Zambon, Myra O McClure, Richard Tedder, Wendy S Barclay, Jake Dunning, Graham P Taylor, Ajit Lalvani, INSTINCT and ATACCC study group
JournalThe Lancet. Microbe (Lancet Microbe) Vol. 4 Issue 6 Pg. e397-e408 (06 2023) ISSN: 2666-5247 [Electronic] England
PMID37031689 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • RNA, Viral
Topics
  • Humans
  • SARS-CoV-2 (genetics)
  • COVID-19 (diagnosis, epidemiology)
  • Prospective Studies
  • RNA, Viral (genetics)
  • Longitudinal Studies
  • Risk Factors
  • Cohort Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: